Page 24 - 73_01
P. 24

MARÍA JOSÉ GÓMEZ-LECHÓN y MARÍA TERESA DONATO  AN. R. ACAD. NAC. FARM.

(63)  CHAPMAN, D. E. (1995): Calcium signalling. Cell 80: 259-268.
(64)  Human P450 allele Nomenclature Web site: www.imm.ki.se/P450alleles.
(65)  INGELMAN-SUNDBERG, M. (2005): The human genome project and novel aspects
(66)  of cytochrome P450 research. Toxicol. Appl. Pharmacol. 207: S52-S56.
(67)  NEBERT, D. W.; MCKINNON, R. A. and PUGA, A. (1996): Human drug-metaboli-
(68)  zing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell
(69)  Biol. 15: 273-280.
      SMITH, D. A.; ABEL, S. M.; HYLAND, R. and JONES, B. C. (1998): Human cyto-
(70)  chrome P450s: selectivity and mesarurement in vivo. Xenobiotica. 28: 1095-
      1128.
(71)  INGELMAN-SUNDBERG, M. (2004); Pharmacogenietics of cytochrome P450 and
(72)  its applications in drug therapy: the past, present and future. Trends Pharma-
      col. Sci. 25: 193-200.
(73)  DAI, D.; TANG, J.; ROSE, R.; HODGSON, E.; BIENSTOCK, R. J.; MOHRENWEISER, H. W.
(74)  and GOLDSTEIN, J. A. (2001): Identification of variants of CYP3A4 and charac-
      terization of their abilities to metabolise testosterone and chlorpyrifos. J.
      Pharmacol. Exp. Ther. 299: 825-831.
      PICHARD, L.; FABRE, I.; FABRE, G.; DOMERGUE, J.; SAINT AUBERT, B.; MOURAD, G.
      and MAUREL, P. (1990): Cyclosporin A drug interactions. Screening for indu-
      cers and inhibitors of cytochrome P-450 (cyclosporin A oxidadase) in prima-
      ry cultures of human hepatocytes and in liver microsomes. Drug Metab.
      Dispos. 18: 595-606.
      PÉREZ, G.; TABARES, B.; JOVER, R.; GÓMEZ-LECHÓN, M. J. and CASTELL, J. V.
      (2003): Semi-automatic quantitative RT-PCR to measure CYP induction by
      drugs in human hepatocytes. Toxicol. in Vitro. 17: 643-649.
      KOMOROSKI, B. J.; ZHANG, S.; CAI, H.; HUTZLER, J. M.; FRYE, R.; TRACY, T. S.;
      STROM, S. C.; LEHMANN, T.; ANG, C. Y.; CUI, Y. Y. and VENKATARAMANAN, R.
      (2004): Induction and inhibition of cytochromes P450 by the St. John’s wort
      constituent hyperforin in human hepatocyte cultures. Drug Metab. Dispos.
      32: 512-518.
      GÓMEZ-LECHÓN, M. J.; DONATO, M. T.; CASTELL J. V. and. JOVER R. (2004): Hu-
      man hepatocytes in primary culture: the choice to investigate drug metabo-
      lism in man. Curr Drug Metab. 5: 443-462.
      PONSODA, X.; PAREJA, E.; GÓMEZ-LECHÓN, M. J.; FABRA, R.; CARRASCO, E.; TRULLEN-
      QUE, R. and CASTELL, J. V. (2001): Drug biotransformation by human hepato-
      cytes. In vitro/in vivo metabolism by cells from the same donor. J. Hepatol.
      34: 19-25.

26
   19   20   21   22   23   24   25   26   27   28   29